西BSARS-CoV-2BA.2,

Xiao-Bin Lin1, Yu-Zhi Yao1,2, Qi-Rong Wen3

  • 1Department of Thyroid and Breast Surgery, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510623, Guangdong Province, China.

Virology journal
|December 20, 2024
PubMed
概括

来自Akebia quinata的calceolarioside B通过结合尖端蛋白和阻止ACE2相互作用来抑制SARS-CoV-2Omicron BA.2的进入. 它还减少了炎症并改变了巨细胞的反应,显示了COVID-19治疗的双抗病毒和免疫调节潜力.